Friday, April 4, 2025
Home Client Page 8

Client

    Latest

    Asia-Pacific: A Region of Stability Amidst Economic Uncertainty

    Client Editor / Curator -
    Contrary to the Western markets, there is a growing consensus that the Asia Pacific is emerging as a relatively safe harbour in...

    Hepion (HEPA) Back in the Spotlight, Gains 230% in May.

    Client Editor / Curator -
    Hepion (HEPA) Phase 2 ‘ALTITUDE-NASH’ Trial Achieves Primary and Secondary Endpoints, Including Improvement in Liver Function and...

    Topical PTSD Drug Poised for Human Trials.

    Client Editor / Curator -
    In a press release issued on February 15, Psycheceutical Bioscience (BWVI), in partnership with iNGENū, a contract research organization in the cannabinoid...

    Report: Expedia, Doordash, eCommerce Fashion Retailer and YouTube All Rolled Into One?

    Client Editor / Curator -
    Society Pass (SOPA) has Acquired and is Operating in Six Verticals, With More to Come. Society Pass currently has...

    Is Smart for Life (SMFL) $4.30, a Bargain Post Reverse Split?

    Client Editor / Curator -
    We Think Yes..! With the year just finished ringing in $17.8 million in revenues, versus a market capitalization of...

    The Ketamine Endgame. Silo Pharmaceutical (SILO).

    Psychedelic Stock Review Editor / Curator -
    James Kuo, M.D. the Vice President of R&D for Silo Pharma (SILO) will speak at the 3rd...

    Maxim Group Targets 175% Gain in Society Pass (SOPA) to $2.75.

    Client Editor / Curator -
    If we average out the two most recent price targets this month, we come out with a potential gain of 337% and...

    Citius Pharmaceuticals Completes Enrollment in Phase 2b Study of Halo-Lido for the Prescription Treatment...

    Client Editor / Curator -
    Topline Results anticipated by the end of Q2 2023 CRANFORD, N.J. , April 3, 2023 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius" or...

    Smart for Life (SMFL) Reports Revenue Increases 96.9% to $17.8 Million for 2022

    Incubator Editor / Curator -
    Smart for Life Reports 2022 Financial Results and Provides Business Update (Bolding by IA Editor)

    Report: Think Equity Updates Society Pass (SOPA). $6.00 Price Target.

    Incubator Editor / Curator -
    Think Equity: Society Pass (Nasdaq: SOPA) – Path to Profitability NEW YORK, NY, March 14, 2023 (GLOBE NEWSWIRE) --...
    1...789...37Page 8 of 37

    Latest article

    Bavarian Nordic (BVNRY) Freeze Dries its MPOX Vaccine!

    2025 Watch List Editor / Curator -
    This is Big News, Honestly. We Are Adding to 2025 Watch List @ $7.36. We last added Bavarian to...

    Biotechs Hammered After FDA Official Resigns, Citing RFK Jr.’s ‘Misinformation And Lies’ (IBD)

    All News Editor / Curator -
    Sorting Through the Wreckage! Full post on Investor's Business Daily. Biotech stocks took a beating Monday...

    Zomedica (ZOMDF) Surges 40% Higher, Friday.

    All News Editor / Curator -
    Stock Surges 40%, After Management Conference Call to Calm the Natives. Insider Buying Unleashed Today? Not...
    The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
    Contact us: [email protected]
    © Managed by Revelers.IO Media Group Inc.